Back to 
Amova Asset Management Americas, Inc.
Amova Asset Management Americas, Inc.
CRSPShowing 8 of 30 quarters
Position history for Amova Asset Management Americas, Inc.'s holdings in CRISPR THERAPEUTICS AG
Yes. Amova Asset Management Americas holds 1,720,097 shares of CRSP (Crispr Therapeutics), worth $93.8M, as of its Q2 2026 13F filing. It reduced the position by 133,778 shares (-7.2%) from Q1 2026. Amova Asset Management Americas has held CRSP in every 13F on record since Q1 2019, 30 quarterly filings. CRSP is 1.2% of Amova Asset Management Americas' reported 13F portfolio.
Current Value
$93.8M
Current Shares
1.7M
Total Value Change
-$45.6M
Total Shares Change
-1.2M
Quarter-by-Quarter History
Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors